Recently, hotspot sequencing of the IDH1 and IDH2 genes in 89 central chondrosarcomas followed by targeted NGS in 54 of them indicated that IDH1/IDH2 mutations are not associated with the overall survival of patients [70]. Here, IDH1 is linked to chondrosarcoma.